Allergan is a technology-driven, global health care company that discovers, develops and commercializes specialty pharmaceutical and medical device products for the ophthalmic, neurological, facial aesthetics, medical dermatological, breast aesthetics, obesity intervention and other specialty markets. Company has products and technologies related to specific disease areas such as glaucoma, retinal disease, dry eye, psoriasis, acne and movement disorders. Furthermore Company discovers, develops and markets medical devices, aesthetics-related pharmaceuticals, and over-the-counter products. Company also has research and development efforts on new therapeutic areas, including gastroenterology, neuropathic pain and genitourinary diseases. Principal markets of the Company are the United States, Europe, Latin America and Asia Pacific.

Acquired Companies: Oculex Pharmaceuticals, Esprit Pharma Inc., EndoArt S.A., Inamed Corp., Group Corneal Laboratories, Vicept Therapeutics, Inc.